Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia/lymphoma: Phase IIb results.
Cancer Sci
; 113(8): 2778-2787, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35579212
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia-Lymphoma, Adult T-Cell
/
Lymphoma, Follicular
Type of study:
Clinical_trials
/
Observational_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Cancer Sci
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: